SCHEMBL30689305

SCHEMBL30689305

C=C(Cc1nc(-c2ccc(Oc3ccccn3)cc2C(F)F)no1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IP6K1 Q92551 2/20 0.38
▸ IP6K3 Q96PC2 2/20 0.38
▸ IP6K2 Q9UHH9 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ SCN7A Q01118 6/20 0.36
▸ KCNH2 Q12809 6/20 0.36
▸ SCN5A Q14524 1/20 0.35
▸ SCN2A Q99250 1/20 0.35
▸ SCN8A Q9UQD0 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ GSTP1 P09211 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31527931 0.88 MAPT (0.42) IP6K1IP6K3IP6K2MAPTSCN7A
SCHEMBL31527956 0.86 GSTP1 (0.43) IP6K1IP6K3IP6K2MAPTSCN7A
SCHEMBL31527877 0.86 GSTP1 (0.44) IP6K1IP6K3IP6K2SCN7AKCNH2
SCHEMBL30689401 0.86 DRD1 (0.44) IP6K1IP6K3IP6K2MAPTSCN7A
SCHEMBL30689444 0.84 SCN7A (0.38) IP6K1IP6K3IP6K2MAPTSCN7A
SCHEMBL30689347 0.82 IP6K1 (0.48) IP6K1IP6K3IP6K2GSTP1ALDH1A1
SCHEMBL30689359 0.81 IP6K1 (0.39) IP6K1IP6K3IP6K2MAPTSCN7A
SCHEMBL30689405 0.79 MAPT (0.36) IP6K1IP6K3IP6K2MAPTGSTP1
SCHEMBL30689399 0.77 MAPT (0.39) MAPTGSTP1ALDH1A1SMN1; SMN2MEN1
SCHEMBL30689409 0.77 FFAR4 (0.41) IP6K1IP6K3IP6K2GSTP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback